Nonalcoholic fatty liver disease is associated with coronary artery calcification. - Wikidata - awgldk - TriplyDB

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

http://www.wikidata.org/entity/Q37316685

about

Nonalcoholic fatty liver disease as a multi-systemic disease NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Autophagy: a new target for nonalcoholic fatty liver disease therapy Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review Comorbidities and Metabolic Derangement of NAFLD Endocrine causes of nonalcoholic fatty liver disease Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review Non-alcoholic fatty liver disease and cardiovascular risk.Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Nonalcoholic fatty liver disease and cardiovascular disease Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis.Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c.The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD.Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study."Non alcoholic fatty liver disease and eNOS dysfunction in humans"Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter.Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival.Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease.

P2860

Q26749290-8D58D429-F0F4-4952-9143-9A55693A07C5 Q26750955-1828C889-EC60-42D4-AD13-4D24F9E315AE Q26751326-D4ED35A6-980A-44B4-991A-8D0CBD4BBAB6 Q26766459-7F430AD7-2EAD-40D8-8D78-9770141F4ACF Q26777147-796705DF-5A96-4534-9221-7AD1B36AAF20 Q26780254-8E7D3B54-F279-452E-9C99-2D6F97319F20 Q26827665-44227E7B-0E31-4031-A99B-C8F5AD5BFF62 Q27692035-74992F9A-8BD7-4D0D-AFFE-3BF92525D694 Q28081066-238582D5-9926-490A-92E7-588A84BECD30 Q33706265-10D7ECA5-C191-48A0-8258-1CD1DBE14343 Q33716191-FA73D3B1-59C7-41EE-9624-6AA03DF95952 Q33844463-98339016-DAAC-47D8-BF8B-FA059F5F2A84 Q33886952-A2CADAB1-DA04-4FB4-9BBC-4C5CB3AD9F51 Q34011629-8FB0BDCF-B3E8-42A5-9A6D-8085C7606CB7 Q34729697-B99C74E5-1CE6-492A-98C4-308E42D9C320 Q34773966-A92D4CC5-C887-4372-984E-2627CAB4287E Q34998991-2109591E-2B31-4AE5-8C72-AB3D90C48A48 Q35188136-CDAD4860-3259-4CB8-ACAE-FC1ACD073F20 Q35258097-631B44BB-B555-4AF8-A4F4-E987C0E5B05E Q35525608-FDD39133-31BA-4C50-B204-732DB32DAE83 Q35533910-B48939F5-4B23-4C67-9F46-E734FED238A2 Q35678746-CDEFA95E-2249-4C48-BAF7-1E8B0B27E104 Q35683422-543427CE-5C4F-4B4F-AD4B-02B70CC06132 Q35848217-1462AD1A-A210-46B5-8947-76B6F6C9B99F Q35921598-BDD13EA1-0B68-409B-AC59-F50B8EE6FC5B Q35995660-721CFDA5-8A49-43B0-B89D-B15C00E4C079 Q36008958-F3BB579D-2D24-4A09-A7CE-5D9850266286 Q36009095-15121549-465C-4A67-AAB9-824210D5FB2C Q36130937-62821B07-C11E-4FEF-A619-F2C307268054 Q36281941-1AD90E6B-BC02-4B5A-BFF6-0FBB7551CD52 Q36298719-9C10EDA8-2C3E-4427-B913-70A4E437C21F Q36334667-DEB91805-7DE8-4CF3-80BF-EE7A4A2EC194 Q36336631-3C7BDDF9-38D8-4608-A8D0-CAAC31C97AD3 Q36359100-8276FACC-BF89-4446-BC9E-26F579473EA2 Q36520139-E9FEFC3C-31F7-48E4-BE6D-08E87119A5A1 Q36569181-6A42D0D8-4F1C-4659-A0C9-46F1D43CBEDA Q36581177-D33598B6-EBC9-4713-8BFE-FB5DF95A9D13 Q36673799-A7FEA02F-A30A-4E50-8259-F27BE214A8CF Q36756206-AD9EA384-06FA-4099-BCAF-E27F630B34DE Q36779181-B31A0505-764E-486B-9D3F-F6EF8449E81B

P2860

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

http://www.wikidata.org/entity/Q37316685

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 July 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

@en

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

@nl

type

label

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

@en

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

@nl

prefLabel

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

@en

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

@nl

P1433

Q37316685-949FDDE8-DE37-49FE-9C7D-9A089357F7D5

P1476

Q37316685-5748E484-73EF-4088-8594-1A87B843BC31

P2093

Q37316685-033A00B3-9C76-4243-A4CF-7A32D40A162E

Q37316685-04FCFB6E-ECAD-47E5-83B0-87A03E5E01A2

Q37316685-43522F50-13B6-4884-86BE-AA19F148DF55

Q37316685-509F10E1-7C92-4967-82E9-1E243DD06072

Q37316685-584995B6-B8F5-49B4-B26B-ECC4B4B18A45

Q37316685-5C5FC5B1-2887-448B-BB2F-AB2014EB3C1E

Q37316685-6CADA3D9-5466-4CF9-977E-8C30DD73EEFD

Q37316685-8C30AE83-1AC0-4681-9017-A9AF87DC58E9

Q37316685-9366F4C9-3C59-438C-8086-3E977A543F9E

Q37316685-951B6E5A-6750-4D22-935B-F7DA86505D67

P2860

Q37316685-0959BABF-1101-407D-BB41-A5D55FAAAD62

Q37316685-19C1AA17-3216-4AC0-96E2-F1884D1C4597

Q37316685-1EAA8634-C3C7-4127-BDF7-BC59B9693B11

Q37316685-1EF8C772-FE8B-44C7-B055-3B261B903456

Q37316685-24076E92-0A22-4A89-87B6-80C30646B8EE

Q37316685-27DF5DC4-26AC-414C-98C9-B5D251E25D8C

Q37316685-2A30EF44-0868-41F3-98A4-E0CAF7DBF64A

Q37316685-2F6935A1-4DE8-431F-93AA-11473A89CDFF

Q37316685-34E5D185-5C18-4E2D-A44B-BB995875E7A5

Q37316685-39314375-E638-4C11-A60E-22181A9AA820

P304

Q37316685-2D8ABF11-4E87-4E3E-A284-D9990462A328

P31

Q37316685-22D314A8-9DAA-4AC6-AA28-B8EAF20B34EF

P356

Q37316685-20F70AD0-10A5-4D82-BC4C-0AE87427CD3B

P407

Q37316685-97B7125F-523C-472E-9AE2-5D8858DE5522

P433

Q37316685-29A383FD-3F6E-4083-9C26-209AEE242232

P478

Q37316685-A969CEC2-B513-438B-B8D1-709801F75F7C

P50

Q37316685-FFD841DE-6663-4974-BD5E-1A6F39719386

P577

Q37316685-D11FA731-FFB6-4499-A0D0-43B5EFC8A9BB

P5875

Q37316685-79F30C7F-3244-4D50-A97C-177CDF83AACC

P698

Q37316685-2D928B62-4043-4E95-B1F9-89FD4FB88406

P932

Q37316685-ECD5C818-558E-44B0-B077-B5EB3DAE3F56

P356

P1433

P1476

Nonalcoholic fatty liver disease is associated with coronary artery calcification

@en

P2093

Dong Ho Lee

http://www.w3.org/2001/XMLSchema#string

Donghee Kim

http://www.w3.org/2001/XMLSchema#string

Eun Ha Park

http://www.w3.org/2001/XMLSchema#string

Hyo-suk Lee

http://www.w3.org/2001/XMLSchema#string

Jin Hwa Kang

http://www.w3.org/2001/XMLSchema#string

Joseph Larson

http://www.w3.org/2001/XMLSchema#string

Sook Hyang Jeong

http://www.w3.org/2001/XMLSchema#string

Su-Yeon Choi

http://www.w3.org/2001/XMLSchema#string

Terry M Therneau

http://www.w3.org/2001/XMLSchema#string

W Ray Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

The metabolic syndrome

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

P304

605-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.25593

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221772014

http://www.w3.org/2001/XMLSchema#string

P698

22271511

http://www.w3.org/2001/XMLSchema#string

P932

3830979

http://www.w3.org/2001/XMLSchema#string